How should a chronic periprosthetic knee infection be managed?

Management of Chronic Periprosthetic Knee Infection

For chronic periprosthetic knee infection, you should proceed with two-stage exchange arthroplasty as the primary treatment strategy, involving complete prosthesis removal, antibiotic-impregnated spacer placement, 4-6 weeks of pathogen-specific intravenous antibiotics, followed by delayed reimplantation after an antibiotic-free interval 1.

Surgical Strategy Selection

The surgical approach depends critically on infection chronicity and prosthesis stability:

When Debridement and Retention (DAIR) is Appropriate:

• Only consider DAIR if: symptoms present <3 weeks duration AND prosthesis implanted <30 days AND well-fixed prosthesis AND no sinus tract present 1
• For chronic infections (which your question specifies), DAIR is not appropriate - the mature biofilm makes retention strategies fail 2

Two-Stage Exchange Protocol (Standard for Chronic PJI):

Stage 1 - Resection:

• Remove all prosthetic components and cement completely
• Perform aggressive debridement of infected periprosthetic tissue
• Collect 3-6 intraoperative tissue samples for aerobic/anaerobic culture 1
• Insert antibiotic-impregnated cement spacer (static or articulating) 1
• Critical pitfall: Some experts avoid spacers for MRSA, small-colony variants, or fungal infections due to potential treatment failure 1

Antimicrobial Therapy Between Stages:

• Administer 4-6 weeks of pathogen-specific IV antibiotics 1
• Follow with antibiotic-free interval of 2-8 weeks before reimplantation 1
• Withhold antibiotics for ≥2 weeks before any culture collection to maximize organism recovery 1

Stage 2 - Reimplantation:

• Delayed reimplantation (after 4-6 weeks of IV therapy plus antibiotic-free period) shows highest success rates 1
• For gram-negative infections specifically, delay reimplantation ≥6 weeks 2
• Collect intraoperative cultures at reimplantation 1
• Success rate: 87% overall 1

Pathogen-Specific Antimicrobial Regimens

For Staphylococcal Infections:

If prosthesis retained (rare in chronic cases):

• 2-6 weeks IV therapy PLUS rifampin 300-450mg PO twice daily
• Continue rifampin plus oral companion drug for 6 months total for knee (3 months for hip) 1
• Preferred companion: ciprofloxacin or levofloxacin 1
• Alternative companions: co-trimoxazole, minocycline/doxycycline, cephalexin 1

If prosthesis removed (standard for chronic infection):

• 4-6 weeks pathogen-specific IV antibiotics 1

For Non-Staphylococcal Organisms:

• 4-6 weeks pathogen-specific IV or highly bioavailable oral therapy 1

When Surgical Cure is Not Feasible

Consider chronic antimicrobial suppression when:

• Patient unsuitable for or refuses further surgery
• Multiple failed exchange attempts
• Severe bone loss or soft tissue compromise 1

Suppression regimens (indefinite duration):

• Cephalexin, dicloxacillin, co-trimoxazole, or minocycline/doxycycline based on susceptibilities 1
• Never use rifampin alone for suppression 1
• Requires regular clinical and laboratory monitoring for efficacy and toxicity 1

Salvage options when exchange fails:

• Resection arthroplasty (Girdlestone procedure)
• Arthrodesis
• Amputation (reserved for necrotizing fasciitis, inability to achieve soft tissue coverage, or failed prior salvage attempts) 1

Critical Diagnostic Requirements

Before any surgical intervention:

• ESR and CRP (combination provides best sensitivity/specificity) 1
• Diagnostic arthrocentesis with cell count, differential, and aerobic/anaerobic cultures 1
• Blood cultures if fever, acute symptoms, or S. aureus suspected 1
• Plain radiographs 1
• Avoid routine bone scans, leukocyte scans, MRI, CT, or PET - not recommended for PJI diagnosis 1

Common Pitfalls to Avoid

1. Attempting DAIR for chronic infection - mature biofilm makes this fail
2. Starting antibiotics before obtaining cultures - dramatically reduces organism recovery
3. Early reimplantation (<4-6 weeks) - associated with higher failure rates 1
4. Using rifampin monotherapy for any indication 1
5. Inadequate tissue sampling - collect minimum 3, optimally 5-6 samples 1
6. Not considering soft tissue reconstruction - when needed, does not compromise infection control and may facilitate eradication 3

The two-stage exchange remains the gold standard in the United States for chronic PJI, with success rates around 87% when properly executed with adequate antibiotic therapy and appropriate timing 1.